Immune modules shared by innate lymphoid cells and T cells

Journal of Allergy and Clinical Immunology

Volumn 138, Issue 5, 2016, Pages 1243-1251

  Robinette, Michelle L ^a   Colonna, Marco ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adaptive; innate; Innate lymphoid cell; lymphocyte; T cell

Indexed keywords

BACTERIUM; CELL LINEAGE; CYTOTOXICITY; FUNGUS; HELMINTH; LYMPHOID CELL; NONHUMAN; PATTERN RECOGNITION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS; ANIMAL; BACTERIAL INFECTION; HELMINTHIASIS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE; MYCOSIS; VIRUS INFECTION;

ANIMALS; BACTERIAL INFECTIONS; HELMINTHIASIS; HUMANS; IMMUNITY, INNATE; LYMPHOCYTES; MYCOSES; VIRUS DISEASES;

EID: 84994831700     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.09.006     Document Type: Review

References (124)

1. 1 Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J.P., Eberl, G., et al. Innate lymphoid cells—a proposal for uniform nomenclature. Nat Rev Immunol 13 (2013), 145–149.
2. 2 Diefenbach, A., Colonna, M., Koyasu, S., Development, differentiation, and diversity of innate lymphoid cells. Immunity 41 (2014), 354–365.
3. 3 Cortez, V.S., Robinette, M.L., Colonna, M., Innate lymphoid cells: new insights into function and development. Curr Opin Immunol 32 (2015), 71–77.
4. 4 Eberl, G., Colonna, M., Di Santo, J.P., McKenzie, A.N., Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology. Science, 348, 2015 aaa6566.
5. 5 Serafini, N., Vosshenrich, C.A., Di Santo, J.P., Transcriptional regulation of innate lymphoid cell fate. Nat Rev Immunol 15 (2015), 415–428.
6. 6 Cording, S., Medvedovic, J., Aychek, T., Eberl, G., Innate lymphoid cells in defense, immunopathology and immunotherapy. Nat Immunol 17 (2016), 755–757.
7. 7 Klose, C.S., Artis, D., Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat Immunol 17 (2016), 765–774.
8. 8 Sun, J.C., Lanier, L.L., NK cell development, homeostasis and function: parallels with CD8(+) T cells. Nat Rev Immunol 11 (2011), 645–657.
9. 9 Ishizuka, I.E., Chea, S., Gudjonson, H., Constantinides, M.G., Dinner, A.R., Bendelac, A., et al. Single-cell analysis defines the divergence between the innate lymphoid cell lineage and lymphoid tissue-inducer cell lineage. Nat Immunol 17 (2016), 269–276.
10. 10 Shih, H.Y., Sciume, G., Mikami, Y., Guo, L., Sun, H.W., Brooks, S.R., et al. Developmental acquisition of regulomes underlies innate lymphoid cell functionality. Cell 165 (2016), 1120–1133.
11. 11 Bando, J.K., Liang, H.E., Locksley, R.M., Identification and distribution of developing innate lymphoid cells in the fetal mouse intestine. Nat Immunol 16 (2015), 153–160.
12. 12 Constantinides, M.G., McDonald, B.D., Verhoef, P.A., Bendelac, A., A committed precursor to innate lymphoid cells. Nature 508 (2014), 397–401.
13. 13 Klose, C.S., Flach, M., Mohle, L., Rogell, L., Hoyler, T., Ebert, K., et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157 (2014), 340–356.
14. 14 Constantinides, M.G., et al. PLZF expression maps the early stages of ILC1 lineage development. Proc Natl Acad Sci U S A 112 (2015), 5123–5128.
15. 15 Spits, H., Bernink, J.H., Lanier, L., NK cells and type 1 innate lymphoid cells: partners in host defense. Nat Immunol 17 (2016), 758–764.
16. 16 Juelke, K., Romagnani, C., Differentiation of human innate lymphoid cells (ILCs). Curr Opin Immunol 38 (2016), 75–85.
17. 17 Fuchs, A., Vermi, W., Lee, J.S., Lonardi, S., Gilfillan, S., Newberry, R.D., et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity 38 (2013), 769–781.
18. 18 Bernink, J.H., Peters, C.P., Munneke, M., te Velde, A.A., Meijer, S.L., Weijer, K., et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 14 (2013), 221–229.
19. 19 Molofsky, A.B., Nussbaum, J.C., Liang, H.E., Van Dyken, S.J., Cheng, L.E., Mohapatra, A., et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Exp Med 210 (2013), 535–549.
20. 20 Mjosberg, J., Bernink, J., Golebski, K., Karrich, J.J., Peters, C.P., Blom, B., et al. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37 (2012), 649–659.
21. 21 Crellin, N.K., Trifari, S., Kaplan, C.D., Cupedo, T., Spits, H., Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J Exp Med 207 (2010), 281–290.
22. 22 Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J.K., et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457 (2009), 722–725.
23. 23 Hepworth, M.R., Monticelli, L.A., Fung, T.C., Ziegler, C.G., Grunberg, S., Sinha, R., et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 498 (2013), 113–117.
24. 24 Sawa, S., Cherrier, M., Lochner, M., Satoh-Takayama, N., Fehling, H.J., Langa, F., et al. Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science 330 (2010), 665–669.
25. 25 Vonarbourg, C., Mortha, A., Bui, V.L., Hernandez, P.P., Kiss, E.A., Hoyler, T., et al. Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes. Immunity 33 (2010), 736–751.
26. 26 Buonocore, S., Ahern, P.P., Uhlig, H.H., Ivanov, I.I., Littman, D.R., Maloy, K.J., et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464 (2010), 1371–1375.
27. 27 Klose, C.S., Kiss, E.A., Schwierzeck, V., Ebert, K., Hoyler, T., d'Hargues, Y., et al. A T-bet gradient controls the fate and function of CCR6-RORgammat+ innate lymphoid cells. Nature 494 (2013), 261–265.
28. 28 Song, C., Lee, J.S., Gilfillan, S., Robinette, M.L., Newberry, R.D., Stappenbeck, T.S., et al. Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation. J Exp Med 212 (2015), 1869–1882.
29. 29 Satoh-Takayama, N., Vosshenrich, C.A., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29 (2008), 958–970.
30. 30 Lee, J.S., Cella, M., McDonald, K.G., Garlanda, C., Kennedy, G.D., Nukaya, M., et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat Immunol 13 (2012), 144–151.
31. 31 Sciume, G., Hirahara, K., Takahashi, H., Laurence, A., Villarino, A.V., Singleton, K.L., et al. Distinct requirements for T-bet in gut innate lymphoid cells. J Exp Med 209 (2012), 2331–2338.
32. 32 Rankin, L.C., Groom, J.R., Chopin, M., Herold, M.J., Walker, J.A., Mielke, L.A., et al. The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway. Nat Immunol 14 (2013), 389–395.
33. 33 Bjorklund, A.K., Forkel, M., Picelli, S., Konya, V., Theorell, J., Friberg, D., et al. The heterogeneity of human CD127(+) innate lymphoid cells revealed by single-cell RNA sequencing. Nat Immunol 17 (2016), 451–460.
34. 34 Gerbe, F., Sidot, E., Smyth, D.J., Ohmoto, M., Matsumoto, I., Dardalhon, V., et al. Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites. Nature 529 (2016), 226–230.
35. 35 Howitt, M.R., Lavoie, S., Michaud, M., Blum, A.M., Tran, S.V., Weinstock, J.V., et al. Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut. Science 351 (2016), 1329–1333.
36. 36 von Moltke, J., Ji, M., Liang, H.E., Locksley, R.M., Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. Nature 529 (2016), 221–225.
37. 37 Mortha, A., Chudnovskiy, A., Hashimoto, D., Bogunovic, M., Spencer, S.P., Belkaid, Y., et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science, 343, 2014, 1249288.
38. 38 Nussbaum, J.C., Van Dyken, S.J., von Moltke, J., Cheng, L.E., Mohapatra, A., Molofsky, A.B., et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502 (2013), 245–248.
39. 39 Voskoboinik, I., Whisstock, J.C., Trapani, J.A., Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol 15 (2015), 388–400.
40. 40 Berke, G., The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu Rev Immunol 12 (1994), 735–773.
41. 41 McLane, L.M., Banerjee, P.P., Cosma, G.L., Makedonas, G., Wherry, E.J., Orange, J.S., et al. Differential localization of T-bet and Eomes in CD8 T cell memory populations. J Immunol 190 (2013), 3207–3215.
42. 42 Kaech, S.M., Cui, W., Transcriptional control of effector and memory CD8+ T cell differentiation. Nat Rev Immunol 12 (2012), 749–761.
43. 43 Pearce, E.L., Mullen, A.C., Martins, G.A., Krawczyk, C.M., Hutchins, A.S., Zediak, V.P., et al. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302 (2003), 1041–1043.
44. 44 Intlekofer, A.M., Takemoto, N., Wherry, E.J., Longworth, S.A., Northrup, J.T., Palanivel, V.R., et al. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol 6 (2005), 1236–1244.
45. 45 Gordon, S.M., Chaix, J., Rupp, L.J., Wu, J., Madera, S., Sun, J.C., et al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36 (2012), 55–67.
46. 46 Cruz-Guilloty, F., Pipkin, M.E., Djuretic, I.M., Levanon, D., Lotem, J., Lichtenheld, M.G., et al. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J Exp Med 206 (2009), 51–59.
47. 47 Townsend, M.J., Weinmann, A.S., Matsuda, J.L., Salomon, R., Farnham, P.J., Biron, C.A., et al. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 20 (2004), 477–494.
48. 48 Daussy, C., Faure, F., Mayol, K., Viel, S., Gasteiger, G., Charrier, E., et al. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J Exp Med 211 (2014), 563–577.
49. 49 Sojka, D.K., Plougastel-Douglas, B., Yang, L., Pak-Wittel, M.A., Artyomov, M.N., Ivanova, Y., et al. Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. Elife, 3, 2014, e01659.
50. 50 Pikovskaya, O., Chaix, J., Rothman, N.J., Collins, A., Chen, Y.H., Scipioni, A.M., et al. Cutting edge: eomesodermin is sufficient to direct type 1 innate lymphocyte development into the conventional NK lineage. J Immunol 196 (2016), 1449–1454.
51. 51 Cortez, V.S., Cervantes-Barragan, L., Robinette, M.L., Bando, J.K., Wang, Y., Geiger, T.L., et al. Transforming growth factor-beta signaling guides the differentiation of innate lymphoid cells in salivary glands. Immunity 44 (2016), 1127–1139.
52. 52 Seillet, C., Rankin, L.C., Groom, J.R., Mielke, L.A., Tellier, J., Chopin, M., et al. Nfil3 is required for the development of all innate lymphoid cell subsets. J Exp Med 211 (2014), 1733–1740.
53. 53 Robinette, M.L., Fuchs, A., Cortez, V.S., Lee, J.S., Wang, Y., Durum, S.K., et al. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat Immunol 16 (2015), 306–317.
54. 54 Szabo, S.J., Kim, S.T., Costa, G.L., Zhang, X., Fathman, C.G., Glimcher, L.H., A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100 (2000), 655–669.
55. 55 Hsieh, C.S., et al. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260 (1993), 547–549.
56. 56 O'Sullivan, T.E., Rapp, M., Fan, X., Weizman, O.E., Bhardwaj, P., Adams, N.M., et al. Adipose-resident group 1 innate lymphoid cells promote obesity-associated insulin resistance. Immunity 45 (2016), 428–441.
57. 57 Bernink, J.H., Krabbendam, L., Germar, K., de Jong, E., Gronke, K., Kofoed-Nielsen, M., et al. Interleukin-12 and -23 control plasticity of CD127(+) group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity 43 (2015), 146–160.
58. 58 Li, J., Doty, A.L., Iqbal, A., Glover, S.C., The differential frequency of Lineage(-)CRTH2(-)CD45(+)NKp44(-)CD117(-)CD127(+)ILC subset in the inflamed terminal ileum of patients with Crohn's disease. Cell Immunol 304-305 (2016), 63–68.
59. 59 Silver, J.S., Kearley, J., Copenhaver, A.M., Sanden, C., Mori, M., Yu, L., et al. Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs. Nat Immunol 17 (2016), 626–635.
60. 60 Peng, H., Jiang, X., Chen, Y., Sojka, D.K., Wei, H., Gao, X., et al. Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J Clin Invest 123 (2013), 1444–1456.
61. 61 Szabo, S.J., Sullivan, B.M., Stemmann, C., Satoskar, A.R., Sleckman, B.P., Glimcher, L.H., Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295 (2002), 338–342.
62. 62 Hwang, E.S., Szabo, S.J., Schwartzberg, P.L., Glimcher, L.H., T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307 (2005), 430–433.
63. 63 Zhu, J., Jankovic, D., Oler, A.J., Wei, G., Sharma, S., Hu, G., et al. The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. Immunity 37 (2012), 660–673.
64. 64 Djuretic, I.M., Levanon, D., Negreanu, V., Groner, Y., Rao, A., Ansel, K.M., Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat Immunol 8 (2007), 145–153.
65. 65 Zhu, J., Yamane, H., Cote-Sierra, J., Guo, L., Paul, W.E., GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res 16 (2006), 3–10.
66. 66 Ebihara, T., Song, C., Ryu, S.H., Plougastel-Douglas, B., Yang, L., Levanon, D., et al. Runx3 specifies lineage commitment of innate lymphoid cells. Nat Immunol 16 (2015), 1124–1133.
67. 67 Knox, J.J., Cosma, G.L., Betts, M.R., McLane, L.M., Characterization of T-bet and eomes in peripheral human immune cells. Front Immunol, 5, 2014, 217.
68. 68 Lupar, E., Brack, M., Garnier, L., Laffont, S., Rauch, K.S., Schachtrup, K., et al. Eomesodermin Expression in CD4+ T cells restricts peripheral Foxp3 induction. J Immunol 195 (2015), 4742–4752.
69. 69 Cheroutre, H., Lambolez, F., Mucida, D., The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol 11 (2011), 445–456.
70. 70 Zhu, J., T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production. Cytokine 75 (2015), 14–24.
71. 71 Monticelli, L.A., Sonnenberg, G.F., Abt, M.C., Alenghat, T., Ziegler, C.G., Doering, T.A., et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12 (2011), 1045–1054.
72. 72 Turner, J.E., Morrison, P.J., Wilhelm, C., Wilson, M., Ahlfors, H., Renauld, J.C., et al. IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J Exp Med 210 (2013), 2951–2965.
73. 73 Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463 (2010), 540–544.
74. 74 Neill, D.R., Wong, S.H., Bellosi, A., Flynn, R.J., Daly, M., Langford, T.K., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464 (2010), 1367–1370.
75. 75 Price, A.E., Liang, H.E., Sullivan, B.M., Reinhardt, R.L., Eisley, C.J., Erle, D.J., et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A 107 (2010), 11489–11494.
76. 76 Paul, W.E., What determines Th2 differentiation, in vitro and in vivo?. Immunol Cell Biol 88 (2010), 236–239.
77. 77 Gold, M.J., Antignano, F., Halim, T.Y., Hirota, J.A., Blanchet, M.R., Zaph, C., et al. Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. J Allergy Clin Immunol 133 (2014), 1142–1148.
78. 78 Halim, T.Y., Krauss, R.H., Sun, A.C., Takei, F., Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 36 (2012), 451–463.
79. 79 Halim, T.Y., Steer, C.A., Matha, L., Gold, M.J., Martinez-Gonzalez, I., McNagny, K.M., et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40 (2014), 425–435.
80. 80 Kim, B.S., Siracusa, M.C., Saenz, S.A., Noti, M., Monticelli, L.A., Sonnenberg, G.F., et al. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med, 5, 2013, 170ra116.
81. 81 Salimi, M., Barlow, J.L., Saunders, S.P., Xue, L., Gutowska-Owsiak, D., Wang, X., et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 210 (2013), 2939–2950.
82. 82 Hoyler, T., Klose, C.S., Souabni, A., Turqueti-Neves, A., Pfeifer, D., Rawlins, E.L., et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37 (2012), 634–648.
83. 83 Zhang, D.H., Cohn, L., Ray, P., Bottomly, K., Ray, A., Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem 272 (1997), 21597–21603.
84. 84 Zheng, W., Flavell, R.A., The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89 (1997), 587–596.
85. 85 Smirnov, D.V., Smirnova, M.G., Korobko, V.G., Frolova, E.I., Tandem arrangement of human genes for interleukin-4 and interleukin-13: resemblance in their organization. Gene 155 (1995), 277–281.
86. 86 Lee, D.U., Rao, A., Molecular analysis of a locus control region in the T helper 2 cytokine gene cluster: a target for STAT6 but not GATA3. Proc Natl Acad Sci U S A 101 (2004), 16010–16015.
87. 87 Yagi, R., Zhu, J., Paul, W.E., An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation. Int Immunol 23 (2011), 415–420.
88. 88 Zhu, J., Min, B., Hu-Li, J., Watson, C.J., Grinberg, A., Wang, Q., et al. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol 5 (2004), 1157–1165.
89. 89 Yagi, R., Zhong, C., Northrup, D.L., Yu, F., Bouladoux, N., Spencer, S., et al. The transcription factor GATA3 is critical for the development of all IL-7Ralpha-expressing innate lymphoid cells. Immunity 40 (2014), 378–388.
90. 90 Zhou, M., Ouyang, W., Gong, Q., Katz, S.G., White, J.M., Orkin, S.H., et al. Friend of GATA-1 represses GATA-3-dependent activity in CD4+ T cells. J Exp Med 194 (2001), 1461–1471.
91. 91 Ouyang, W., Lohning, M., Gao, Z., Assenmacher, M., Ranganath, S., Radbruch, A., et al. Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 12 (2000), 27–37.
92. 92 Hegazy, A.N., Peine, M., Helmstetter, C., Panse, I., Frohlich, A., Bergthaler, A., et al. Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity 32 (2010), 116–128.
93. 93 Ohne, Y., Silver, J.S., Thompson-Snipes, L., Collet, M.A., Blanck, J.P., Cantarel, B.L., et al. IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity. Nat Immunol 17 (2016), 646–655.
94. 94 Eyerich, S., Eyerich, K., Pennino, D., Carbone, T., Nasorri, F., Pallotta, S., et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119 (2009), 3573–3585.
95. 95 Guo, X., Qiu, J., Tu, T., Yang, X., Deng, L., Anders, R.A., et al. Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection. Immunity 40 (2014), 25–39.
96. 96 Rankin, L.C., Girard-Madoux, M.J., Seillet, C., Mielke, L.A., Kerdiles, Y., Fenis, A., et al. Complementarity and redundancy of IL-22-producing innate lymphoid cells. Nat Immunol 17 (2016), 179–186.
97. 97 Teunissen, M.B., Munneke, J.M., Bernink, J.H., Spuls, P.I., Res, P.C., Te Velde, A., et al. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. J Invest Dermatol 134 (2014), 2351–2360.
98. 98 Villanova, F., Flutter, B., Tosi, I., Grys, K., Sreeneebus, H., Perera, G.K., et al. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J Invest Dermatol 134 (2014), 984–991.
99. 99 Dyring-Andersen, B., Geisler, C., Agerbeck, C., Lauritsen, J.P., Gudjonsdottir, S.D., Skov, L., et al. Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin. Br J Dermatol 170 (2014), 609–616.
100. 100 Ciccia, F., Guggino, G., Rizzo, A., Saieva, L., Peralta, S., Giardina, A., et al. Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis. Ann Rheum Dis 74 (2015), 1739–1747.
101. 101 Cols, M., Rahman, A., Maglione, P.J., Garcia-Carmona, Y., Simchoni, N., Ko, H.B., et al. Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency. J Allergy Clin Immunol 137 (2016), 1206–1215.
102. 102 Hepworth, M.R., Fung, T.C., Masur, S.H., Kelsen, J.R., McConnell, F.M., Dubrot, J., et al. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4(+) T cells. Science 348 (2015), 1031–1035.
103. 103 Ivanov, I.I., McKenzie, B.S., Zhou, L., Tadokoro, C.E., Lepelley, A., Lafaille, J.J., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126 (2006), 1121–1133.
104. 104 Ciofani, M., Madar, A., Galan, C., Sellars, M., Mace, K., Pauli, F., et al. A validated regulatory network for Th17 cell specification. Cell 151 (2012), 289–303.
105. 105 Withers, D.R., Hepworth, M.R., Wang, X., Mackley, E.C., Halford, E.E., Dutton, E.E., et al. Transient inhibition of ROR-gammat therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells. Nat Med 22 (2016), 319–323.
106. 106 Kiss, E.A., Vonarbourg, C., Kopfmann, S., Hobeika, E., Finke, D., Esser, C., et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334 (2011), 1561–1565.
107. 107 Qiu, J., Heller, J.J., Guo, X., Chen, Z.M., Fish, K., Fu, Y.X., et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36 (2012), 92–104.
108. 108 Cella, M., Colonna, M., Aryl hydrocarbon receptor: Linking environment to immunity. Semin Immunol 27 (2015), 310–314.
109. 109 Basu, R., O'Quinn, D.B., Silberger, D.J., Schoeb, T.R., Fouser, L., Ouyang, W., et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 37 (2012), 1061–1075.
110. 110 Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., et al. Phenotypic and functional features of human Th17 cells. J Exp Med 204 (2007), 1849–1861.
111. 111 Lee, Y.K., Turner, H., Maynard, C.L., Oliver, J.R., Chen, D., Elson, C.O., et al. Late developmental plasticity in the T helper 17 lineage. Immunity 30 (2009), 92–107.
112. 112 Cella, M., Otero, K., Colonna, M., Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc Natl Acad Sci U S A 107 (2010), 10961–10966.
113. 113 Walker, J.A., Barlow, J.L., McKenzie, A.N., Innate lymphoid cells—how did we miss them?. Nat Rev Immunol 13 (2013), 75–87.
114. 114 Zook, E.C., Kee, B.L., Development of innate lymphoid cells. Nat Immunol 17 (2016), 775–782.
115. 115 Koues, O.I., Collins, P.L., Cella, M., Robinette, M.L., Porter, S.I., Pyfrom, S.C., et al. Distinct gene regulatory pathways for human innate versus adaptive lymphoid cells. Cell 165 (2016), 1134–1146.
116. 116 Li-Weber, M., Krammer, P.H., Regulation of IL4 gene expression by T cells and therapeutic perspectives. Nat Rev Immunol 3 (2003), 534–543.
117. 117 Bedoui, S., Gebhardt, T., Gasteiger, G., Kastenmuller, W., Parallels and differences between innate and adaptive lymphocytes. Nat Immunol 17 (2016), 490–494.
118. 118 Guo, L., Wei, G., Zhu, J., Liao, W., Leonard, W.J., Zhao, K., et al. IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci U S A 106 (2009), 13463–13468.
119. 119 Robinson, D., Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 7 (1997), 571–581.
120. 120 Yang, J., Zhu, H., Murphy, T.L., Ouyang, W., Murphy, K.M., IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production. Nat Immunol 2 (2001), 157–164.
121. 121 Chung, Y., Chang, S.H., Martinez, G.J., Yang, X.O., Nurieva, R., Kang, H.S., et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30 (2009), 576–587.
122. 122 Meisel, C., Bonhagen, K., Lohning, M., Coyle, A.J., Gutierrez-Ramos, J.C., Radbruch, A., et al. Regulation and function of T1/ST2 expression on CD4+ T cells: induction of type 2 cytokine production by T1/ST2 cross-linking. J Immunol 166 (2001), 3143–3150.
123. 123 Coquet, J.M., Schuijs, M.J., Smyth, M.J., Deswarte, K., Beyaert, R., Braun, H., et al. Interleukin-21-producing CD4(+) T cells promote type 2 immunity to house dust mites. Immunity 43 (2015), 318–330.
124. 124 Guo, L., Huang, Y., Chen, X., Hu-Li, J., Urban, J.F. Jr., Paul, W.E., Innate immunological function of TH2 cells in vivo. Nat Immunol 16 (2015), 1051–1059.